Nomura Holdings
ICPT

Nomura Holdings’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Nomura Holdings’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-117,300
Closed -$2.9M – 2365
2020
Q4 		$2.9M Buy
+117,300
New +$3.89M ﹤0.01% 721
2019
Q4 		– Sell
-30,000
Closed -$1.98M – 1396
2019
Q3 		$1.98M Buy
+30,000
New +$2.01M 0.01% 653

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nomura Holdings's ICPT Position: Q1 2022 in Review

Nomura Holdings sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2022, closing a stake of 12,691 shares — an estimated $207K sold.

Nomura Holdings first reported a position in ICPT in Q2 2013 and held it in 15 quarters. The position peaked at $12M in Q3 2014. 148 funds tracked by Wall St. Rank hold ICPT as of Q1 2022.

  • Nomura Holdings reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
  • Nomura Holdings sold 12,691 Intercept Pharmaceuticals, Inc. shares in Q1 2022, an estimated $207K.
  • Nomura Holdings first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 15 quarters.
  • Nomura Holdings's Intercept Pharmaceuticals, Inc. position peaked at $12M in Q3 2014.
  • 148 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2022.

Based on Nomura Holdings's 13F filing for Q1 2022, filed 18 May 2022.